SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3557 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3482Interesting given George recent controversial comments on Alzheimer treatmentFelix B-12/10/2022
3481TREATMENT OF CEREBROVASCULAR DISEASE WITH NEUROGENIC LOCUS NOTCH HOMOLOG PROTEINBiotechwantabe-12/8/2022
3480LIBTAYO® (CEMIPLIMAB-RWLC) IN COMBINATION WITH CHEMOTHERAPY APPROVED BY THEBiotechwantabe-11/8/2022
3479Performance highlights in Q3 - page 14 Ex-U.S. U.S. 1,549 2,314 511 Worldwide grBiotechwantabe-10/28/2022
3478ASCO Honors Dr. Craig B. Thompson With the 2022 Science of Oncology Award Nice Biotechwantabe-10/3/2022
3477AMERICAN ACADEMY OF OPHTHALMOLOGY 2022 ANNUAL MEETING Detailed results of studyBiotechwantabe-9/30/2022
3476 Not sure how good this is? I’m sure they’ll let us know Monday Novel RegenerBiotechwantabe-9/10/2022
3475This is good news, bring more hope for those hard to treat amd/dme conditions. Miljenko Zuanic19/8/2022
3474Trial supports dosing Elyea with more drug at longer intervals, finance.yahoo.coA.J. Mullen-9/8/2022
3473REGN swimming against the tide today. Perhaps due to this, finance.yahoo.com. A.J. Mullen-9/1/2022
3472investors.alnylam.com investor.regeneron.com Genetic discoveries BioBait17/27/2022
3471< Thoughts on REGN buying out SNY for PD1? I see it as a vote of confidence aBioBait-6/9/2022
3470Thoughts on REGN buying out SNY for PD1? I see it as a vote of confidence and wFelix B-6/8/2022
3469Dupi did better than I expected 46% growth. sanofi.comBioBait-4/29/2022
3468REGENERON TO ACQUIRE CHECKMATE PHARMACEUTICALS AND ITS INVESTIGATIONAL IMMUNE ACBioBait-4/19/2022
3467Sanofi’s -mega brand-dupi New target 13bBioBait-3/31/2022
3466BA.2-Resistance data were available before FDA action, so I am surprised by Mr. Miljenko Zuanic-3/30/2022
3465Setback for GSK/VIR COVID mAb: investorshub.advfn.comDewDiligence_on_SI-3/25/2022
3464Correction - thank god no one reads my messages. 2022 guesstimate Dupi 6.2 +3BioBait-3/24/2022
3463Safety and Tolerability of Regeneron Anti-SARS-CoV-2 Monoclonal Antibody(Ies) inBioBait-3/24/2022
3462why the recent climb?Felix B-3/19/2022
3461Regeneron's doesn't seem affected by the news that a partner's patenA.J. Mullen-3/1/2022
3460investorshub.advfn.com :-)DewDiligence_on_SI-2/23/2022
3459Kodiak Stock Pummeled After Attempt To Improve On Regeneron's Blockbuster BaBioBait12/23/2022
3458If that's the timeline then *hopefully we'll be at an endemic stage and Felix B-2/16/2022
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News